Certificate of Analysis
CJC-1295 (No DAC) + Ipamorelin
Batch Report on File
99.3%Purity
ProductCJC-1295 (No DAC) + Ipamorelin
VariantCJC-1295 (No DAC) 5mg + Ipamorelin 5mg
Lot / Batch #PV-2608-CJCI-01
LabeledCJC-1295 (No DAC) 5mg + Ipamorelin 5mg
ActualCJC-1295 4.78mg · Ipamorelin 5.16mg
TestedSeptember 8, 2026
Analytical Results
Chromatographic Purity · HPLC-UV/MS 99.3%
CJC-1295 (No DAC) · 5mg label · HPLC-UV/MS · ID confirmed 4.78mg · 95.6% of label
Ipamorelin · 5mg label · HPLC-UV/MS · ID confirmed 5.16mg · 103.2% of label
Endotoxins · USP 85 · LAL clot <0.5 EU
Elemental Impurities · USP 233 · As/Cd/Hg + duplicate Hg row on report ND on all reported analytes
Performing Laboratory
Independent third-party laboratory
Independent third-party laboratory · USP / compendial testing standards
Disclaimer & Scope of Testing
For research use only. Not for human or veterinary consumption, and not for diagnostic, therapeutic, or clinical use. The product analyzed has not been evaluated by the U.S. Food and Drug Administration.
Testing is performed by an independent, third-party laboratory using the methods identified on the applicable report. Results apply only to the specific sample and lot identified above. Test results reflect the sample as received; subsequent handling, storage, or modification may alter the attributes reported here. The laboratory report is the controlling source for analytical methods, results, limits, and any acceptance criteria.